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Role of reactive oxygen species in
cis-dichlorodiammineplatinum-induced cytotoxicity
on bladder cancer cells
A Miyajima, J Nakashima, K Yoshioka, M Tachibana, H Tazaki and M Murai
Department of Urology, Keio University School of Medicine, Shinanomachi, Shinjuku, Tokyo 160, Japan
Summary This study was undertaken to investigate the intracellular induction of reactive oxygen species (ROS) by cis-dichloro-
diammineplatinum (CDDP) and the augmentation of theircytotoxicity in bladder cancer cells (KU7) by enhancement of ROS generation by the
glutathione (GSH) depletors buthionine sulphoximine (BSO) and diethylmaleate (DEM). CDDP-induced cytotoxicity in KU7 cells and its
modulation by GSH depletors were determined using spectrophotometric measurement with crystal violet staining. The effects of GSH
depletors on intracellular GSH levels were confirmed using the GSH reductase-DTNB recycling method. Intracellular ROS generation
induced by CDDP with or without GSH depletors was estimated from the amount of intracellular dichlorofluorescein (DCF), an oxidized
product of dichlorofluorescein (DCFH), which was measured with an anchored cell analysis and sorting system. The cytotoxic effects of CDDP
(IC50 15.0 ± 2.5gIM) were significantly enhanced by BSO (IC50 9.3 ± 2.6 gM, P < 0.01) and DEM (IC50 10.3 ± 0.3 gM, P< 0.01). BSO and DEM
produced a significant depletion in intracellular GSH levels (9.6 ± 0.4 nmol 10-6 cells, 17.9 ± 1.0 nmol 10-6 cells) compared with the controls
(30.5 ± 0.6 nmol 10-6 cells). Intracellular DCF production in KU7 cells treated with CDDP (1.35 ± 0.33 g1M) was significantly enhanced by the
addition of BSO (4.43 ± 0.33 gM) or DEM (3.12 ± 0.22 gM) at 150 min. These results suggest that ROS may play a substantial role in CDDP-
induced cytotoxicity and that GSH depletors augment its cytotoxicity through an enhancement of ROS generation in bladder cancer cells.
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Reactive oxygen species (ROS) have been reported by Fridovich
(1978) to cause cell damage, and many other reports have
diversely demonstrated a clear relationship between ROS and
tissue damage. ROS-mediated cell death may be important in the
pathogenesis of several neurodegenerative disorders (Coyle and
Puttfarrcken, 1993; Busciglio and Yankner, 1995). Moreover,
oxidative tissue injury has been observed to be central in reperfu-
sion injury of ischaemic tissues in myocardium, kidney and brain
(Bulkley, 1983). Indeed, reperfused tissues have been protected in
ischaemic diseases including renal transplantation and myocardial
ischaemia by inhibitors of ROS (McCord, 1985). In the cytotoxi-
city of effective anti-tumour agents including adriamycin (ADR)
(Meijer et al, 1987), bleomycin (Sausville et al, 1978) and tumour
necrosis factor (TNF) (Yamauchi et al, 1989), ROS have been
noted as playing a contributing role.
CDDP is an anti-tumour agent effective for treating various
human cancers of the brain, head and neck, stomach, ovary, testis
and bladder. Its anti-tumour activity is attributed primarily to its
ability to form DNA-platinum cross-linked adducts (Zwelling et
al, 1979). In addition, CDDP is reported to cause apoptosis (Evans
and Dive, 1993). On the other hand, CDDP-induced nephrotoxi-
city (Sugihara et al, 1987) and emesis (Torii et al, 1993) - the
resulting major side effects - are also believed to be related to
ROS generation. Uslu and Bonavida (1996) have suggested that
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the synergistic cytotoxic effects of TNF-a and CDDP on ovarian
cancer cells are associated with ROS induction.
The mechanism of CDDP-induced cytotoxicity, however, has
not been fully elucidated. The present study was therefore under-
taken to investigate a role of ROS in the CDDP-induced cytotoxi-
city on bladder cancer cells.
MATERIALS AND METHODS
Chemicals and drugs
Cis-dichlorodiammineplatinum (CDDP) was obtained from
Nippon Kayaku (Tokyo, Japan). Buthionine sulphoximine (BSO),
diethylmaleate (DEM) and dichlorofluorescein diacetate (DCFH-
DA) were purchased from Sigma (St Louis, MO, USA). RPMI-
1640 medium, 0.25% trypsin and phosphate-buffered saline (PBS)
were supplied from Gibco (Grand Island, NY, USA). Hydrogen
peroxide was acquired from Wako (Osaka, Japan). DCFH-DA was
dissolved in ethanol to prepare the 5 mm solution. 5,5'-Dithiobis-
2-nitrobenzoic acid (DTNB), glutathione reductase and NADPH
were obtained from Boehringer-Mannheim (Germany).
Cell line
KU7 cells, which are an established bladder cancercell line from a
patient with transitional cell carcinoma ofthe bladder (Shibayama
et al, 1991), were incubated in a monolayer cell culture and main-
tained in 75-cm2 Corning culture flasks (Tokyo, Japan) containing
RPMI-1640 medium supplemented with 10% heat-inactivated
fetal bovine serum and carbenicillin sodium in a humidified
atmosphere of 5% carbondioxide-95% air at 37°C. The culture
medium was renewed every 3 days.
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Cytotoxicity assay
Cytotoxicity was determined as reported previously (Nakashima
et al, 1991) with a modification of the photometric procedure
described by Nedwin et al (1985). Aliquots of KU7 cells (1 x 104
per well) were seeded in a total volume of 100 gl ofmedium, in a
96-multiwell plate with round bottoms (Corning), and the experi-
ments were performed under the same conditions as described
previously. Following a 24-h preincubation, the cells were
exposed to CDDP in the concentration range of 3.3-53.3 giM for
24 h. To assess the effect ofBSO or DEM on CDDP-induced cyto-
toxicity, the cells were preincubated with 9.3 mm BSO for 4 h or
with 0.2 mm DEM for 4 h. After the preincubation period, the
supematant was discarded and medium containing CDDP, in the
concentration range described above, was then added to the wells.
After incubation, the plates were washed and cytotoxicity was
determined by staining the plates with 0.2% crystal violet (in 2%
ethanol). The absorbance value of each well was determined at
550 nm with a 405-nm reference beam by a microplate reader
(Bio-Rad, Tokyo, Japan). A linear relationship (r = 0.953) was
seen between the absorbance value and the cell number excluding
trypan blue. Cell growth was expressed as the percentage of
absorbance value compared with controls.
Measurement of intracellular glutathione (GSH)
KU7 cells were seeded in culture dishes andexposed to GSH deple-
tors (BSO, 9.3 mm; DEM, 0.2 mM) for different periods (0, 4, 8,
12 h). After exposure to GSH depletors, the supernatant was
removed and the cells were detached with trypsin. The cells were
collected by centrifugation and washed with PBS. This cell pellet
was suspended in PBS (1 x 106 cells ml-1). The cells were homoge-
nized using aPolytron homogenizer andcentrifuged at4°C (5000g,
30 min). The supematant was then harvested and the GSH concen-
tration was determined with the glutathione reductase-DTNB recy-
cling method, as reported previously (Tietze, 1969). The supernatant
(1.5 ml) was incubated with40 ,l ofDTNB ataconcentration of3.8
mm for 2 min. An aliquot (200 gl) of glutathione reductase
(6 units ml-') and 100 pl of NADPH (5.4 mM) were then added to
the mixture, and the concentration of GSH was estimated by using
spectrophotometric measurement.
Measurement of intracellular reactive oxygen species
To determine the net intracellular levels of ROS generated by
CDDP, we used DCFH-DA, which is permeable in cells and
interacts with intracellular ROS, to generate fluorescent DCF as
reported previously (Bass et al, 1983; Cathcart et al, 1983).
DCFH-DA is a stable non-fluorescent product that is activated to
non-fluorescent DCFH by alkaline hydrolysis penetrating the
cell membrane. DCFH is oxidized rapidly to highly fluorescent
DCF by ROS.
The relationship between fluorescence intensity and the various
concentrations of DCF was determined in each experiment. The
amount of DCF produced was then calculated from the fluores-
cence intensity, and the amount of ROS was subsequently esti-
mated from DCF production. Fluorescence intensity in the cells
was determined by using an anchored cell analysis and sorting
system (ACAS 570, Meridian Instruments, Okemos, MI, USA)
with an excitation wavelength of 488 nm and an emission wave-
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Figure 1 Effects of GSH depletors on CDDP-induced cytotoxicity in KU7
cells. BSO (9.3 mM) caused a significant increase in CDDP-induced
cytotoxicity in KU7 cells (P < 0.01). DEM (0.2 mM) produced asignificant increase in CDDP-induced cytotoxicity in KU7 cells (P < 0.01). Each value
represents the mean ± s.d. *Significantly different from CDDP alone (BSO).










Figure 2 Effects of hydrogen peroxide on time course of DCF production in
KU7 cells. KU7 cells were incubated with 30 gM hydrogen peroxide, which
caused a significant increase in DCF production (P < 0.05). Each value
represents the mean ± s.d. of five measurements. *Significantly different from
the value at 0 min
microwells (Meridian Instruments) at a cell density of 1 x 105 ml-',
and cultured for 24 h. After this preincubation period, the medium
was discarded and the attached cells were rinsed five times with
PBS containing 5 mm glucose (PBSg). The cells were exposed to
5 gM DCFH-DA solution for 15 min at 370C. The treated cells
were washed several times with PBSg. The cells were then
exposed to CDDP and subjected to a time-plot programme in
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Figure 3 Effects of CDDP on time course of DCF production in KU7 cells.
DCF production in KU7 cells treated with CDDP (16.7gM) were significantly
higher than those of controls (P< 0.05). Each value represents the
mean ± s.d. of five measurements. *Significantly different from controls
ACAS. The cells were subsequently scanned to quantitate the
average fluorescence intensity per cell. KU7 cells were exposed to
CDDP (16.7 [JM) and ROS generation was determined serially, as
described above. As a positive control, the fluorescence intensity
of KU7 cells pretreated with DCFH-DA solution was assessed in
the presence of 30 JIM hydrogen peroxide. In the experiments
conducted to determine the BSO and DEM effects in CDDP-
induced ROS generation, the attached cells on glass-bottomed
microwells were preincubated with BSO of9.3 mm for 4 h or with
DEM of0.2 mm for 4 h before the exposure of the cells to CDDP
at a concentration of 16.7 JM.
Statistical methods
Data on IC50 values, GSH concentrations and the net intracellular
ROS generation are reported herein as mean values plus or minus
the standard deviation (s.d.). Variables of different groups were
compared using the Student's t-test. A level of P < 0.05 was
accepted as being statistically significant.
RESULTS
Cytotoxicity assay
CDDP induced cytotoxic effects in KU7 cells in a dose-dependent
manner. The effects of BSO or DEM in CDDP-induced cytotoxi-
city were assessed (Figure 1). BSO at a concentration of 18.6 mM
or higher and DEM at a concentration of0.4 mm orhigher demon-
strated cytotoxic effects on KU7 cells after 4 h. However, BSO
(9.3 mM) or DEM (0.2 mM) showed no cytotoxic effects on KU7
cells after 4 h. We then used BSO and DEM at these concentra-
tions. The IC50 of CDDP in the presence of BSO (9.3 mM) was
9.3 ± 2.6 JIM (n = 5), which was significantly lower than that of
CDDP alone (15.0 ± 2.5 JIM, n = 12, P < 0.01). The IC50 ofCDDP
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Figure 4 Effects of GSH depletors on CDDP-induced DCF production. BSO
(9.3 mM) and DEM (0.2 mM) both produced a significant enhancement in
DCF production (P< 0.05). Each value represents the mean ± s.d.
*Significantly different from CDDP alone (DEM). tSignificantly different from
CDDP alone (BSO)
in the presence ofDEM (0.2 mM) was 10.3 ± 0.3 ,UM (n = 7), which
was significantly lower than that ofcontrols (P < 0.01). These data
indicate that these GSH depletors significantly enhanced CDDP-
induced cytotoxicity.
Intracellular glutathione concentration
Intracellular GSH concentrations in KU7 cells following 4 h expo-
sure to BSO (9.3 mM) and DEM (0.2 mM) were 9.6 ± 0.4 nmol I0
cells and 17.9 ± 1.0 nmol 10- cells (n = 3), respectively signifi-
cantly lower (P < 0.01) than in the controls (32.0 ± 3.2 nmol 10"
cells). In the 8-h assay, GSH concentrations were also significantly
decreased (P < 0.01) (BSO, 7.3 ± 0.3 nmol 106 cells; DEM,
11.1 + 0.2 nmol I0" cells) when compared with the controls
(33.8 + 1.1 nmol I0" cells). In the 12-h assay, GSH concentrations
were significantly decreased (P < 0.01) (BSO, 2.2 ± 0.8 nmol I0"
cells; DEM, 10.5 ± 0.2 nmol 0I cells) when compared with the
controls (30.5 ± 0.6 nmol I0" cells). These GSH depletors signifi-
cantly decreased the intracellular concentrations ofGSH in a time-
dependent manner.
Measurement of intracellular ROS generation
In the preliminary examination, hydrogen peroxide (30 ,UM) caused
a significant increase in DCF production (Figure 2). CDDP
produced a significant increase in DCF production in a time-
dependent manner. Intracellular DCF production induced by
CDDP (16.7 gIM) for 150 min was 1.35 ± 0.05 gM (P < 0.01),
which was significantly higher than that of the controls
(0.13 ± 0.04 ,UM) (Figure 3). BSO and DEM also produced a signif-
icant enhancement in the CDDP-induced DCF production in a
time-dependent manner (Figure 4). Intracellular DCF production
induced by CDDP in the presence of 9.3 mM BSO and 0.2 mM
DEM at 150 min was 4.43 ± 0.33 ,UM and 3.12 ± 0.22 ,UM respec-
tively, significantly higher than that induced by CDDP alone
(1.35 ± 0.05 gIM). These data suggest that CDDP induces ROS
generation and that GSH depletors significantly enhance CDDP-
induced ROS generation.
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DISCUSSION
CDDP is a platinum complex that consists oftwo carrier ligands of
ammonia and two leaving groups of chloride. The mechanisms of
CDDP-induced cytotoxicity have long been recognized to be due
to the conversion of CDDP to a di-ucl-acquo complex of CDDP,
which forms an interstrand cross-link with double-strand DNA to
prevent DNA synthesis (Zwelling et al, 1979; Micetich et al,
1983). Moreover, this reaction is likely to cause apoptosis (Evans
and Dive, 1993). However, until now it has not been possible to
describe fully the mechanism of CDDP-induced cytotoxicity,
although a considerable amount of research has thus far been
performed. The cytotoxicity of ADR has been reported to depend
on its enzymatic defence against ROS, and levels of scavenging
enzymes, including glutathione peroxidase or glutathione-S-trans-
ferase, modulate the cytotoxicity ofADR (Mimnaugh et al, 1989).
Tumour necrosis factor (TNF) was also noted to induce ROS
generation, and it was presumed that ROS play a salient role in
the tumour cell killing induced by TNF (Yamauchi et al, 1989).
Therefore ROS, reportedly, significantly serves in the cytotoxicity
of several chemotherapeutic agents (Sausville et al, 1978; Meijer
et al, 1987) and TNF (Yamauchi et al, 1989). It could thus be
anticipated to enhance the cytotoxic effects through the increase
in ROS generation induced by anti-tumour agents.
CDDP is also known to induce nephrotoxicity. Recent reports
have shown that CDDP causes nephrotoxicity through ROS gener-
ation (Sugihara et al, 1987). It has been demonstrated that CDDP
induced nephrotoxicity can be presented by GSH in renal tissues
(Anderson et al, 1990). Furthermore, it has been reported that GSH
reacts with ROS and plays a role in the reduction of hydrogen
peroxide andorganic peroxides (Meister, 1983; Martensson, 1991)
and that CDDP is inactivated by direct binding to GSH (Meijer et
al, 1990). Ishikawa et al (1993) showed that CDDP reacts with
intracellular GSH and that the resulting glutathione-platinum
complex is actively exported from leukaemia cells via a GS-X
pump. In addition, GSH has been considered to contribute to
multidrug resistance in human renal cell carcinoma (Micksch et al,
1990) and lung cancer (Meijer et al, 1990).
Recently, GSH depletors have been found to decrease mito-
chondrial GSH and damage mitochondria, which are a resource of
ROS (Meister, 1995). The lethal effects of excessive GSH defi-
ciency in animals such as new born rats and guinea pigs appear to
be related to multiorgan failure, involving mitochondrial and other
damage in liver, kidney and lung (Martensson et al, 1991). Our
results also provide significant evidence that GSH depletors
induce intracellular GSH deficiency and enhance CDDP-induced
cytotoxicity in bladder cancer cells, whereas GSH depletor alone
had no significant cytotoxicity effect at the concentration and
exposure time used in this study.
CDDP-induced emesis has been reported to be enhanced by
ferric chloride, which is known to catalyse the production ofcyto-
toxic ROS, and to be ameliorated by desferrioxamine, an iron
chelator (Matsuki et al, 1994). These results suggest that ROS are
involved in CDDP-induced emesis. In CDDP-induced acute renal
failure, mitochondrial respiration has been reported to be reduced
(Gordon et al, 1986). Moreover, TNF-ax-induced inhibition of
mitochondrial electron transport, together with the effects
observed for different mitochondrial inhibitors, favours the propo-
sition that TNF-ac also damages the mitochondrial respiratory
chain which, consequently, results in increased production ofROS
inside the mitochondrion (Schulze-Osthoff et al, 1992). Uslu and
Bonavida (1996) reported that the cytotoxicity ofCDDP and TNF-
ax against ovarian cancer cells was inhibited in the presence of
mitochondrial respiratory chain inhibitors, suggesting that the
synergistic cytotoxic effects of CDDP and TNF-a are associated
with ROS.
Determining the amount of ROS has been difficult because the
ROS-mediated reaction is quite rapid in living cells (Fridovich,
1978). The amount of ROS induced by TNF in tumorigenic fibro-
blast cells and sarcoma cells was estimated by the formation of
methane from dimethylsulphoxide in a previous investigation
(Yamauchi et al, 1989). In the present study, the net intracellular
generation ofROS was estimated by DCF production from DCFH.
Our study demonstrates that CDDP significantly increases ROS
generation in bladder cancer cells when compared with controls,
and that combination with CDDP and GSH depletors significantly
augments CDDP-induced ROS generation.
In an effort to shed light on this deficiency, CDDP has been
found to stimulate ROS generation in bladder cancer cells. The
present study suggests that ROS may play an important role in
CDDP-induced cytotoxicity and that GSH depletors augment this
cytotoxicity by enhancing ROS generation in bladder cancer cells.
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